Barclays PLC has disclosed a 3.08% interest in HIPGNOSIS SONGS FUND LTD as of June 3, 2024. The disclosure includes 36,124,027 ordinary shares owned and/or controlled, representing 2.99% of the total, and 1,230,269 short positions, amounting to 0.10%. Additionally, there are cash-settled derivatives with 1,149,261 shares (0.10%) and 35,946,621 short positions (2.97%).
Barclays PLC has engaged in various dealings related to HIPGNOSIS SONGS FUND LTD's ordinary shares. This includes purchases ranging from 2,228 to 2,085,854 shares at prices between 1.0120 and 1.0145 GBP per unit. Sales transactions were also conducted, with quantities ranging from 1,652 to 1,429,157 shares and prices between 1.0100 and 1.0150 GBP per unit.
Furthermore, the disclosure outlines cash-settled derivative transactions, such as SWAP and CFD, involving increasing and decreasing long and short positions. Stock-settled derivative transactions, including options, were not reported. The disclosure also confirms that there are no indemnity or other dealings arrangements, agreements, arrangements, or understandings relating to options or derivatives.
This disclosure provides insight into Barclays PLC's significant interest and dealings in HIPGNOSIS SONGS FUND LTD, offering transparency to the market and stakeholders. The disclosed positions and transactions reflect Barclays PLC's current involvement with the company's securities as of the specified date.